Cogent Biosciences, Inc.
COGT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001622229
In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.
Superinvestors holding COGT, Q2 2026
No superinvestor reported holding COGT in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of COGT each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2026
0 superinvestors holding at quarter end
- Sold out
- Duquesne Family Office
Q4 2025
1 superinvestor holding at quarter end
- Added
- Duquesne Family Office (+109.0%)
Q3 2025
1 superinvestor holding at quarter end
Q3 2021
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)